Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans
- PMID: 1997444
- PMCID: PMC258358
- DOI: 10.1128/iai.59.3.996-1001.1991
Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans
Abstract
We examined whether immunization with a newly developed oral cholera vaccine would elicit gut-derived antibody-producing cells in the blood and in distant mucosal tissues, such as the minor salivary glands, in 30 adult Swedish volunteers. The results of this study demonstrated that this vaccine indeed induced production of specific antibody-producing cells against the cholera toxin B subunit in both peripheral blood and salivary glands. The response in blood, which after primary and booster immunizations comprised both immunoglobulin A (IgA) and IgG antibody-forming cells, was highly transient and preceded the response in salivary glands; the latter response was restricted to the IgA isotype. The results provide further evidence of the existence of a common mucosal immune system in humans. Furthermore, these findings support previous observations that in animals, the cholera toxin B subunit may be a useful carrier protein for preparing enteric vaccines against pathogens encountered at intestinal and extraintestinal mucosal sites.
Similar articles
-
Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.J Clin Invest. 1991 Jul;88(1):143-8. doi: 10.1172/JCI115270. J Clin Invest. 1991. PMID: 1905327 Free PMC article.
-
Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.Vaccine. 1994 Sep;12(12):1078-82. doi: 10.1016/0264-410x(94)90176-7. Vaccine. 1994. PMID: 7998416 Clinical Trial.
-
Mucosal immunity: implications for vaccine development.Immunobiology. 1992 Feb;184(2-3):157-79. doi: 10.1016/S0171-2985(11)80473-0. Immunobiology. 1992. PMID: 1587541 Review.
-
Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination.Clin Exp Immunol. 1994 Feb;95(2):222-6. doi: 10.1111/j.1365-2249.1994.tb06514.x. Clin Exp Immunol. 1994. PMID: 8306495 Free PMC article.
-
Cholera as a model for research on mucosal immunity and development of oral vaccines.Curr Opin Immunol. 1992 Aug;4(4):387-91. doi: 10.1016/s0952-7915(06)80027-0. Curr Opin Immunol. 1992. PMID: 1388838 Review.
Cited by
-
Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis.Infect Immun. 1991 Dec;59(12):4391-7. doi: 10.1128/iai.59.12.4391-4397.1991. Infect Immun. 1991. PMID: 1937797 Free PMC article.
-
In silico and in vivo studies of gp120-HIV-derived peptides in complex with G4-PAMAM dendrimers.RSC Adv. 2020 May 27;10(35):20414-20426. doi: 10.1039/d0ra00840k. eCollection 2020 May 27. RSC Adv. 2020. PMID: 35517739 Free PMC article.
-
Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers.Gut. 2002 Nov;51(5):634-40. doi: 10.1136/gut.51.5.634. Gut. 2002. PMID: 12377799 Free PMC article. Clinical Trial.
-
Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction.Mucosal Immunol. 2016 Jul;9(4):884-93. doi: 10.1038/mi.2015.107. Epub 2015 Oct 28. Mucosal Immunol. 2016. PMID: 26509875
-
Sulphasalazine inhibits human antigen-specific immune responses in vivo.Ann Rheum Dis. 2007 Apr;66(4):481-5. doi: 10.1136/ard.2006.059881. Epub 2006 Sep 19. Ann Rheum Dis. 2007. PMID: 16984937 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous